Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Breast Cancer Research and Treatment|March 9, 2017
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patientsCatherine Bingham, Sandra V Fernandez, Patricia Fittipaldi, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2021
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasmsAlexander W MacFarlane, Ho-Man Yeung, R Katherine Alpaugh, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast ConditionsDaniel L Adams, Diane K Adams, R Katherine Alpaugh, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 18, 2014
Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC testDaniel L Adams, Steingrimur Stefansson, Christian Haudenschild, et al.Cancers|July 29, 2023
Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic SettingsDaniel J Gironda, Raymond C Bergan, R Katherine Alpaugh, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer (E3194): a trial coordinated by the Eastern Cooperative Oncology GroupHossein Borghaei, R Katherine Alpaugh, Patricia Bernardo, et al.Pancreas|July 31, 2008
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinomaSteven J Cohen, R Katherine Alpaugh, Irma Palazzo, et al.Breast Cancer Research : BCR|May 5, 2016
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomasDaniel L Adams, Diane K Adams, Steingrimur Stefansson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2013
Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.Molecular Imaging and Biology|April 4, 2014
Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET/CT scans in healthy volunteersMohan Doss, Hartmuth C Kolb, Joseph C Walsh, et al.Pageof 6